Literature DB >> 1623329

A simple method to assess osteoclast-mediated bone resorption using unfractionated bone cells.

Y Takada1, M Kusuda, K Hiura, T Sato, H Mochizuki, Y Nagao, M Tomura, M Yahiro, Y Hakeda, H Kawashima.   

Abstract

To determine osteoclastic bone resorption we established a simple assay system in which unfractionated cells obtained from femora of 13-day-old mice were cultured on a dentine slice and the number of osteoclasts and their induced pit area on the slices were measured. When the bone cells (1 x 10(5) cells/dentine slice) were cultured in the presence of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] or human parathyroid hormone (hPTH) for 4 days, at which time newly-formed osteoclasts were not detected, the pit area was dose-dependently increased, being a 4.3- or 4.1-fold respective increase over the control at a 10(-8) M concentration of hormones. Chick calcitonin (cCT) inhibited the osteoclastic bone resorption induced by either of these hormones. cCT alone also suppressed the bone resorption by the cells (3 x 10(5) cells/dentine slice). These findings indicate that 1,25(OH)2D3 or hPTH may mainly activate pre-existing osteoclasts, resulting in increased bone resorption, and that cCT may suppress this osteoclastic activity. When 1,25(OH)2D3 or hPTH was added to the cells pre-cultured in factor-free medium for 6 days, at which time pre-existing osteoclasts had almost degenerated, new osteoclasts were formed, resulting in an increase in pit formation. Thus this system is a useful method which could more sensitively evaluate the effects of hormones or factors on osteoclast formation and activation than other previous systems.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1623329     DOI: 10.1016/0169-6009(92)90785-c

Source DB:  PubMed          Journal:  Bone Miner        ISSN: 0169-6009


  22 in total

Review 1.  Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence.

Authors:  P V Giannoudis; N K Kanakaris; T A Einhorn
Journal:  Osteoporos Int       Date:  2007-08-12       Impact factor: 4.507

2.  Estrogen directly down-regulates the bone-resorbing activity of mature osteoclasts through nuclear estrogen receptor alpha.

Authors:  H Mano; Y Hakeda; M Kumegawa
Journal:  Cytotechnology       Date:  2001-01       Impact factor: 2.058

3.  Characterization of zinc effect to inhibit osteoclast-like cell formation in mouse marrow culture: interaction with dexamethasone.

Authors:  S Kishi; M Yamaguchi
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

4.  Development of a new method for obtaining osteoclasts from endosteal surfaces.

Authors:  L G May; C V Gay
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-05       Impact factor: 2.416

5.  Lack of effect of ipriflavone on osteoclast motility and bone resorption in in vitro and ex vivo studies.

Authors:  K Notoya; S Taketomi; M Tsuda
Journal:  Calcif Tissue Int       Date:  1993-07       Impact factor: 4.333

6.  Induction of osteoclast characteristics in cultured avian blood monocytes; modulation by osteoblasts and 1,25-(OH)2 vitamin D3.

Authors:  R J van't Hof; A C Tuinenburg-Bol Raap; P J Nijweide
Journal:  Int J Exp Pathol       Date:  1995-06       Impact factor: 1.925

7.  Effect of 24R,25-dihydroxyvitamin D3 on the formation and function of osteoclastic cells.

Authors:  H Yamato; R Okazaki; T Ishii; E Ogata; T Sato; M Kumegawa; K Akaogi; N Taniguchi; T Matsumoto
Journal:  Calcif Tissue Int       Date:  1993-03       Impact factor: 4.333

8.  Zinc compounds inhibit osteoclast-like cell formation at the earlier stage of rat marrow culture but not osteoclast function.

Authors:  M Yamaguchi; S Kishi
Journal:  Mol Cell Biochem       Date:  1996-05-24       Impact factor: 3.396

9.  Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4-VCAM-1 adhesion and macrophage inflammatory protein-1alpha and MIP-1beta production.

Authors:  Masahiro Abe; Kenji Hiura; Shuji Ozaki; Shinsuke Kido; Toshio Matsumoto
Journal:  J Bone Miner Metab       Date:  2008-12-05       Impact factor: 2.626

10.  A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase.

Authors:  Kazuaki Niikura; Mikiko Takano; Masae Sawada
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.